The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

Article usage
Posted July 14, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (174)
- Allergy and Immunology (420)
- Anesthesia (97)
- Cardiovascular Medicine (896)
- Dermatology (102)
- Emergency Medicine (257)
- Epidemiology (8764)
- Gastroenterology (404)
- Genetic and Genomic Medicine (1857)
- Geriatric Medicine (177)
- Health Economics (387)
- Health Informatics (1284)
- Health Policy (642)
- Hematology (206)
- HIV/AIDS (392)
- Medical Education (193)
- Medical Ethics (52)
- Nephrology (218)
- Neurology (1748)
- Nursing (102)
- Nutrition (265)
- Oncology (962)
- Ophthalmology (281)
- Orthopedics (107)
- Otolaryngology (176)
- Pain Medicine (117)
- Palliative Medicine (41)
- Pathology (263)
- Pediatrics (556)
- Primary Care Research (218)
- Public and Global Health (3975)
- Radiology and Imaging (650)
- Respiratory Medicine (534)
- Rheumatology (215)
- Sports Medicine (166)
- Surgery (196)
- Toxicology (37)
- Transplantation (106)
- Urology (79)